CZAPSKA, M.; BABKIEWICZ, K.; PABIS, S.; SKÓRZYŃSKA-DZIDUSZKO, K. Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus. Journal of Education, Health and Sport, [S. l.], v. 8, n. 12, p. 335–351, 2018. Disponível em: https://apcz.umk.pl/JEHS/article/view/6378. Acesso em: 29 mar. 2024.